Metastatic urothelial carcinoma
Showing 1 - 25 of >10,000
Urothelial Carcinoma, Metastatic Urothelial Carcinoma, Locally Advanced Urothelial Carcinoma Trial in Philadelphia (Enfortumab
Not yet recruiting
- Urothelial Carcinoma
- +2 more
- Enfortumab vedotin
- Pembrolizumab
-
Philadelphia, PennsylvaniaFox Chase Cancer Center - Philadelphia
Jun 27, 2023
Metastatic Urothelial Carcinoma Trial in Guangzhou (utidelone injection)
Recruiting
- Metastatic Urothelial Carcinoma
- utidelone injection
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hospital, Sun Yat-sen University
May 29, 2023
Metastatic Urothelial Carcinoma Trial in Québec (Bicalutamide 150 mg, Placebo)
Not yet recruiting
- Metastatic Urothelial Carcinoma
- Bicalutamide 150 mg
- Placebo
-
Québec, CanadaCHU de Québec - Université Laval
Sep 6, 2023
Metastatic Urothelial Carcinoma Trial in Tampa, Boston (Ipilimumab, Nivolumab, Sacituzumab govitecan)
Recruiting
- Metastatic Urothelial Carcinoma
- Ipilimumab
- +2 more
-
Tampa, FloridaMoffitt Cancer Center
Jan 24, 2023
Urothelial Cancer, Metastatic Urothelial Carcinoma, Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter Trial in
Recruiting
- Urothelial Cancer
- +3 more
- Sacituzumab Govitecan (SG)
- Enfortumab vedotin-ejfv (EV)
-
Boston, MassachusettsDana Farber Cancer Institute
Sep 28, 2022
Metastatic Urothelial Carcinoma, Urothelial Tumors Trial (Coformulated favezelimab/pembrolizumab, Coformulated
Not yet recruiting
- Metastatic Urothelial Carcinoma
- Urothelial Neoplasms
- Coformulated favezelimab/pembrolizumab
- +3 more
- (no location specified)
Apr 26, 2023
Locally Advanced Urothelial Carcinoma, Metastatic Urothelial Carcinoma, Solid Tumor Trial (TYRA-300)
Not yet recruiting
- Locally Advanced Urothelial Carcinoma
- +3 more
- (no location specified)
Sep 15, 2022
Urothelial Carcinoma Trial (disitamab vedotin, pembrolizumab, gemcitabine)
Not yet recruiting
- Urothelial Carcinoma
- disitamab vedotin
- +4 more
- (no location specified)
Jun 9, 2023
Advanced Urothelial Carcinoma, Locally Advanced Urothelial Carcinoma, Metastatic Urothelial Carcinoma Trial in Sacramento
Recruiting
- Advanced Urothelial Carcinoma
- +3 more
- Pembrolizumab
- Selinexor
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Jun 28, 2022
Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter
Recruiting
- Locally Advanced Bladder Urothelial Carcinoma
- +13 more
- Pembrolizumab
- Propranolol Hydrochloride
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Jun 8, 2022
Advanced Bladder Urothelial Carcinoma, Advanced Ureter Urothelial Carcinoma, Metastatic Bladder Urothelial Carcinoma Trial in
Recruiting
- Advanced Bladder Urothelial Carcinoma
- +23 more
- Atezolizumab
- +2 more
-
Riverside, California
- +8 more
Jul 16, 2022
Metastatic Urothelial Carcinoma Trial (Pembrolizumab (200mg), Pembrolizumab (400mg), Monitoring)
Not yet recruiting
- Metastatic Urothelial Carcinoma
- Pembrolizumab (200mg)
- +2 more
- (no location specified)
Sep 18, 2023
Urothelial Carcinoma, Renal Cell Carcinoma, Melanoma Trial (BGB-A445, Tislelizumab)
Not yet recruiting
- Urothelial Carcinoma
- +2 more
- (no location specified)
Dec 15, 2022
Urothelial Carcinoma Associated 1 RNA, Human Trial (Pembrolizumab, Cisplatin, Carboplatin)
Active, not recruiting
- Urothelial Carcinoma Associated 1 RNA, Human
- Pembrolizumab
- +3 more
- (no location specified)
Aug 18, 2022
Metastatic Cancer, Urothelial Carcinoma Trial (avelumab (PD-L1 inhibitor immunotherapy) + lurbinectedin)
Not yet recruiting
- Metastatic Cancer
- Urothelial Carcinoma
- avelumab (PD-L1 inhibitor immunotherapy) + lurbinectedin
- (no location specified)
Dec 19, 2022
Carcinoma, Transitional Cell, HER-2 Gene Amplification Trial in Beijing (Trastuzumab)
Recruiting
- Carcinoma, Transitional Cell
- HER-2 Gene Amplification
-
Beijing, ChinaNational Cancer Center/Cancer Hospital, Chinese Academy of Medic
Mar 31, 2022
Urothelial Carcinoma Trial in United States (Gemcitabine, Cisplatin, Ipilimumab)
Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter
Recruiting
- Locally Advanced Bladder Urothelial Carcinoma
- +18 more
- Enfortumab Vedotin
- Erdafitinib
-
Los Angeles, California
- +2 more
Jun 28, 2022
Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter
Not yet recruiting
- Locally Advanced Bladder Urothelial Carcinoma
- +31 more
- Diagnostic Laboratory Biomarker Analysis
- Nivolumab
-
Houston, TexasM D Anderson Cancer Center
Aug 18, 2022
Metastatic Urothelial Carcinoma, Bladder Cancer Trial in Tampa, Atlanta, Salt Lake City (Cabozantinib, Pembrolizumab)
Recruiting
- Metastatic Urothelial Carcinoma
- Bladder Cancer
-
Tampa, Florida
- +2 more
Jun 9, 2022
Kidney Cancer, Renal Cell Carcinoma, Clear Cell Carcinoma Trial in Dallas (13C-Glucose, 13C-Acetate, 13C-Lactate)
Recruiting
- Kidney Cancer
- +11 more
- 13C-Glucose
- +4 more
-
Dallas, TexasUniversity of Texas Southwestern Medical Center
Dec 1, 2022
Infiltrating Bladder Urothelial Carcinoma With Squamous Differentiation, Locally Advanced Urothelial Carcinoma, Metastatic
Recruiting
- Infiltrating Bladder Urothelial Carcinoma With Squamous Differentiation
- +3 more
- Cabozantinib S-malate
- +3 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Aug 8, 2022
Urine Omics Predicting IO Therapy Responses in mUC Patients
Recruiting
- Metastatic Urothelial Carcinoma
- No intervention required
-
Taipei, TaiwanNational Taiwan University Hospital
Dec 19, 2021